05.06.2013 Views

The IX t h Makassed Medical Congress - American University of Beirut

The IX t h Makassed Medical Congress - American University of Beirut

The IX t h Makassed Medical Congress - American University of Beirut

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(P=0.006, odds ratio=4.59), respectively.<br />

IDA is common in Lebanese children and is associated with increased blood lead levels, lack <strong>of</strong><br />

iron supplementation, and cultural dietary habits. Remedial measures such as iron fortification <strong>of</strong><br />

commonly consumed food are needed on the national level. Lead exposure must be controlled<br />

and awareness must be raised about the potentially devastating consequences <strong>of</strong> combined<br />

iron deficiency and lead poisoning on young children.<br />

NON-INVASIVE VENTILATION IN CHILDREN: INDICATIONS AND PREDICTIVE<br />

FACTORS FOR THE OUTCOME<br />

Francis Leclerc MD-PhD<br />

Non-invasive ventilation (NIV) provides respiratory support without endotracheal tube or<br />

tracheostomy. It usually refers to continuous positive airway (CPAP) or bilevel positive airway<br />

pressure (BiPAP) delivered through nasal prongs, facemasks or head boxes. Many evidence is<br />

accumulating that it may be beneficial for children with acute respiratory failure (ARF). In a 5-year<br />

retrospective study, 83 <strong>of</strong> 114 children (77%) were treated successfully with NIV; the success rate<br />

was 100% for acute chest syndrome, 92% for immuno-compromised children, 87% for community<br />

acquired pneumonia, while only 22% for acute respiratory distress syndrome (ARDS) (1). In a<br />

3-year prospective study, 32 episodes <strong>of</strong> ARF in 26 children (pneumonia: 46%) were treated with<br />

NIV by a volumetric ventilator; there was a clinical (at 2-4 hours) and radiological (at 24 hours)<br />

improvement and only 4 children required intubation (2). <strong>The</strong> mechanism by which NIV acts was<br />

recently studied by Essouri et al. in 12 children with hypercapnic ARF by the mean <strong>of</strong> an esogastric<br />

catheter: the authors observed that NIV was associated with a significant improvement<br />

<strong>of</strong> breathing pattern, gas exchange and respiratory muscle output (3). Also, NIV limits alveolar<br />

collapse (1). NIV includes simpler technology and equipment allowing use in settings other<br />

than critical care units; this means that patients may benefit from additional respiratory support<br />

earlier in the progression <strong>of</strong> their illness. Furthermore, NIV is associated with less need for sedation<br />

and a decrease in nosocomial ventilator associated infections. This is, at least partly, due to<br />

the diminished need for intubation, as reported by Yanez et al in their prospective randomised<br />

controlled study (intubation rate: 60 % in controls, 28% in NIV group) (4).<br />

When use NIV for acute respiratory failure?<br />

Whilst for some problems, such as upper airway obstruction, stenting <strong>of</strong> the upper airway with<br />

CPAP is <strong>of</strong>ten adequate to improve overall ventilation, there are other conditions where additional<br />

BiPAP to enhance minute ventilation is used. For ARF, a combination <strong>of</strong> factors determines whether<br />

assisted ventilation is needed, most commonly the degree <strong>of</strong> respiratory distress and whether the<br />

child is tiring, exhausted, unable to vocalise, looking frightened, has altered conscious level or<br />

deteriorating vital signs. <strong>The</strong> child’s clinical condition usually guides the need for intubation and<br />

critical care, but continuous measurement <strong>of</strong> pulse oxygen saturation (SpO 2 ) and PtcCO 2 (5)<br />

(as NIV is generally used for hypercapnic ARF) may help identify the progression <strong>of</strong> respiratory<br />

failure and allow for earlier intervention with NIV. Several papers have summarized the published<br />

evidence on NIV for ARF in adult patients: the results are presented in table 1 (6-8). <strong>The</strong> authors<br />

<strong>of</strong> these meta-analyses concluded that NIV for ARF was supported by strong evidence from<br />

patients with chronic obstructive pulmonary disease, acute cardiogenic pulmonary edema<br />

59

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!